Published in Brain Res Bull on October 17, 1979
In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry. J Neurochem (2011) 1.81
Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Br J Pharmacol (1994) 0.81
Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain. Psychopharmacology (Berl) (2016) 0.76
Release of histamine from stomach by vagus-stimulating drugs: association with gastric acid secretion. Fed Proc (1966) 1.67
Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience (1984) 1.66
Visual responses of neurons in the dorsolateral amygdala of the alert monkey. Exp Neurol (1979) 1.41
Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience (1987) 1.38
Transport and storage of biogenic amines. Annu Rev Pharmacol (1972) 1.28
Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration (1996) 1.27
Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry (2000) 1.26
Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res (1983) 1.21
The mode of sodium dependency of the adrenergic neuron amide carrier. Evidence for a second, sodium-dependent, optically specific and reserpine-sensitive system. J Pharmacol Exp Ther (1969) 1.20
Corticomotoneuronal connections of precentral cells detected by postspike averages of EMG activity in behaving monkeys. Brain Res (1976) 1.15
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Exp Neurol (2006) 1.12
Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience (1999) 1.11
Activity of neurones in the inferotemporal cortex of the alert monkey. Brain Res (1977) 1.10
A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pump. Biochem Pharmacol (1967) 1.09
On the inability to produce supersensitivity to catecholamines in intestinal smooth muscle. J Pharmacol Exp Ther (1969) 1.06
Studies in vitro of amine uptake mechanisms in heart. Biochem Pharmacol (1966) 1.03
Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence. Neurosci Lett (1987) 1.02
Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. Eur J Pharmacol (1980) 1.00
Specific binding of reserpine. Association with norepinephrine depletion. Biochem Pharmacol (1969) 1.00
Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol (1996) 0.99
Locus coeruleus cell loss in the aging human brain: a non-random process. J Comp Neurol (1995) 0.98
Upregulation of estrogen receptors in the forebrain of aromatase knockout (ArKO) mice. Mol Cell Endocrinol (2000) 0.98
Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells. J Biol Chem (1983) 0.98
Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem Pharmacol (1980) 0.98
Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histology. Bone (2000) 0.96
Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss. Neurology (1985) 0.96
Electrophysiological properties of mouse dopamine neurons: in vivo and in vitro studies. Neuroscience (1984) 0.95
Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin. Neuroscience (1996) 0.95
Hypothalamic pathology in Alzheimer's disease. Neurosci Lett (1987) 0.94
In vivo monoamine oxidase inhibition by d-amphetamine. Biochem Pharmacol (1980) 0.94
The mode of potassium action on the adrenergic neuron amine transport system. Life Sci (1969) 0.94
Amine uptake and storage mechanisms in the corpus striatum of rat and rabbit. J Pharmacol Exp Ther (1971) 0.93
The relative functional availability of brain noradrenaline and dopamine storage pools. J Pharm Pharmacol (1977) 0.93
Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings. N Engl J Med (1983) 0.93
Catecholamine systems as the neural substrate for intracranial self-stimulation: a hypothesis. Brain Res (1974) 0.92
Electrophysiological and pharmacological evidence for the existence of distinct subpopulations of nigrostriatal dopaminergic neuron in the rat. Neuroscience (1988) 0.92
Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience (1987) 0.92
In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. J Pharmacol Exp Ther (2000) 0.90
Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase. Neurosci Lett (1985) 0.90
Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter. Biochem Pharmacol (1974) 0.89
Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain. Neuroscience (1999) 0.89
Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease. Ann Neurol (1991) 0.88
Mesencephalic dopaminergic unit activity in the behaviorally conditioned rat. Life Sci (1981) 0.87
Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Brain Res Mol Brain Res (1998) 0.87
Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT. Bone (2005) 0.87
On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin. Biochem Pharmacol (1969) 0.85
The latency of activation of neurones in the lateral hypothalamus and substantia innominata during feeding in the monkey. Brain Res (1979) 0.85
Electrophysiological examination of the ventral tegmental (A10) area in the rat. Brain Res (1980) 0.84
Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons. Brain Res Bull (1984) 0.84
Dopamine receptor antagonism by the novel antianxiety drug, buspirone. J Neurosci (1983) 0.84
Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain. J Pharmacol Exp Ther (1973) 0.84
The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase. Pharmacol Rev (1966) 0.84
Further studies on the nature of persistent reserpine binding: evidence for reversible and irreversible binding. Biochem Pharmacol (1971) 0.83
Distribution of clozapine in the rat: localization in lung. J Pharmacol Exp Ther (1978) 0.83
Responses of primate locus coeruleus and subcoeruleus neurons to stimulation at reinforcing brain sites and to natural reinforcers. Brain Res (1976) 0.83
The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter. Neuroscience (1998) 0.82
Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man. J Neural Transm (1983) 0.82
Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J Pharm Pharmacol (1976) 0.82
A radioenzymatic assay for plasma adenosine. Anal Biochem (1984) 0.81
Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.81
Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine. Eur J Pharmacol (1982) 0.81
The reserpine receptor. Life Sci (1978) 0.81
Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.80
Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons. Biochem Pharmacol (1966) 0.80
Optical specificity of monoamine oxidase. Life Sci (1966) 0.80
The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons. Brain Res Mol Brain Res (1996) 0.80
Eating behavior and plasma beta-endorphin in bulimia. Am J Clin Nutr (1986) 0.80
Characteristics of storage and release of metaraminol in the rat heart. Biochem Pharmacol (1972) 0.80
Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. Neuroreport (1997) 0.79
Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation. Brain Res Bull (1981) 0.79
On the nature of the adrenergic neuron extragranular amine binding site. J Neural Transm (1974) 0.79
Opioid receptors in midbrain dopaminergic regions of the rat. II. Kappa and delta receptor autoradiography. J Neural Transm Gen Sect (1993) 0.79
Medial prefrontal cortical projections to the region of the dorsal periventricular catecholamine system. Neuroscience (1981) 0.78
Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity. Eur J Pharmacol (1982) 0.78
Further evidence for a sodium-dependent, optically specific and reserpine-sensitive amine carrier mechanism at the adrenergic neuron. J Pharmacol Exp Ther (1971) 0.78
Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems. J Pharm Pharmacol (1978) 0.78
Mesostriatal projections in BALB/c and CBA mice: a quantitative retrograde neuroanatomical tracing study. Brain Res Bull (1989) 0.78
An autoradiographic, semistereotaxic mapping of major projections from locus coeruleus and adjacent nuclei in Macaca mulatta. Brain Res (1978) 0.78
Factors affecting access to menopause information. Menopause (2000) 0.78
Midbrain dopamine neurons: differential responses to amphetamine isomers. Brain Res (1981) 0.78
Acupuncture relief of chronic pain syndrome correlates with increased plasma met-enkephalin concentrations. Lancet (1983) 0.78
Endorphin-related peptides in rat cerebrospinal fluid. Brain Res (1983) 0.77
Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons. Neurodegeneration (1995) 0.77
Increased sensitivity in a specific fluorometric method for brain histamine. Biochem Pharmacol (1966) 0.77
Evidence for alpha-methyl-m-tyrasmine as a false dopamine-like transmitter. J Pharm Pharmacol (1972) 0.77
Monoaminergic mechanisms in aversive brain stimulation. Physiol Behav (1975) 0.77
A subpopulation of mesocortical dopamine neurons possesses autoreceptors. Eur J Pharmacol (1984) 0.77
Anatomical and electrophysiological characterization of presumed dopamine-containing neurons within the supramammillary region of the rat. Brain Res Bull (1988) 0.77